Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy

References

• ResnikoffSPascoliniDEtya’aleDGlobal data on visual impairment in the year 2002Bull World Health Organ2004821184485115640920
   PubMed Web of Science ®Google Scholar
• BaltussenRSyllaMMariottiSPCost-effectiveness analysis of cataract surgery: a global and regional analysisBull World Health Organ200482533834515298224
   PubMed Web of Science ®Google Scholar
• CongdonNO’ColmainBKlaverCCCauses and prevalence of visual impairment among adults in the United StatesArch Ophthalmol2004122447748515078664
   PubMed Web of Science ®Google Scholar
• HigashideTSugiyamaKUse of viscoelastic substance in ophthalmic surgery – focus on sodium hyaluronateClin Ophthalmol200821213019668386
   PubMedGoogle Scholar
• DuanPLiuYLiJThe comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysisGraefes Arch Clin Exp Ophthalmol2017255463964928130595
   PubMed Web of Science ®Google Scholar
• DickHBSchwennOKrummenauerFKristRPfeifferNInflammation after sclerocorneal versus clear corneal tunnel phacoemulsificationOphthalmology2000107224124710690818
   PubMed Web of Science ®Google Scholar
• da Rocha LimaBPichiFNucciPSrivastavaSKLowderCYFibrin reaction after uveitic cataract surgery: treatment and preventionEur J Ophthalmol201424462662824519510
   PubMed Web of Science ®Google Scholar
• Porela-TiihonenSKaarnirantaKKokkiMPurhonenSKokkiHA prospective study on postoperative pain after cataract surgeryClin Ophthalmol201371429143523885165
   PubMedGoogle Scholar
• Garcia-GutierrezSQuintanaJMAguireUImpact of clinical and patient-reported outcomes on patient satisfaction with cataract extractionHealth Expect201417676577522784407
   PubMed Web of Science ®Google Scholar
• FeenyDSpritzerKHaysRDAgreement about identifying patients who change over time: cautionary results in cataract and heart failure patientsMed Decis Making201232227328622009666
   PubMed Web of Science ®Google Scholar
• Porela-TiihonenSKokkiHKaarnirantaKKokkiMRecovery after cataract surgeryActa Ophthalmol201694Suppl 2134
   Web of Science ®Google Scholar
• GreenbergPBHavnaerAOettingTAGarcia-FerrerFJCataract surgery practice patterns in the United States Veterans Health AdministrationJ Cataract Refract Surg201238470570922365578
   PubMed Web of Science ®Google Scholar
• OkekeCOQuigleyHAJampelHDAdherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid studyOphthalmology2009116219119919084273
   PubMed Web of Science ®Google Scholar
• HermannMMUstündagCDiestelhorstMElectronic compliance monitoring of topical treatment after ophthalmic surgeryInt Ophthalmol201030438539020373127
   PubMedGoogle Scholar
• GrahamROPeymanGAIntravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitisArch Ophthalmol19749221491544211214
   PubMedGoogle Scholar
• TanDTCheeSPLimLLimASRandomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammationOphthalmology199910622232319951469
   PubMed Web of Science ®Google Scholar
• ChangDFGarciaIHHunkelerJDMinasTPhase II results of an intraocular steroid delivery system for cataract surgeryOphthalmology199910661172117710366088
   PubMed Web of Science ®Google Scholar
• TanDTCheeSPLimLThengJvan EdeMRandomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eyeOphthalmology2001108122172218111733254
   PubMed Web of Science ®Google Scholar
• WadoodACArmbrechtAMAspinallPADhillonBSafety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsificationJ Cataract Refract Surg200430476176815093636
   PubMed Web of Science ®Google Scholar
• GungorSGBulamBAkmanAColakMComparison of intracam-eral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgeryIndian J Ophthalmol201462886125230962
   PubMed Web of Science ®Google Scholar
• JamilAZAhmedAMirzaKAEffect of intracameral use of dex-amethasone on corneal endothelial cellsJ Coll Physicians Surg Pak201424424524824709236
   PubMed Web of Science ®Google Scholar
• DonnenfeldEHollandEDexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a ran-domized, placebo-controlled, Phase III trialOphthalmology2018125679980629397189
   PubMed Web of Science ®Google Scholar
• CourseyTGHenrikssonJTMarcanoDCDexamethasone nano-wafer as an effective therapy for dry eye diseaseJ Control Release201521316817426184051
   PubMed Web of Science ®Google Scholar
• Rodríguez VillanuevaJRodríguez VillanuevaLGuzmán NavarroMPharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trendsInt J Pharm20175161–234235127889587
   PubMed Web of Science ®Google Scholar
• MogensenTHBergRSPaludanSRØstergaardLMechanisms of dexamethasone-mediated inhibition of Toll-like receptor signaling induced by Neisseria meningitidis and Streptococcus pneumoniaeInfect Immun200876118919717938219
   PubMed Web of Science ®Google Scholar
• PrabhuPDubeyAParthVGhateVInvestigation of hydrogel membranes containing combination of gentamicin and dexamethasone for ocular deliveryInt J Pharm Investig201554214
   Google Scholar
• KulkarniPSMancinoMStudies on intraocular inflammation produced by intravitreal human interleukins in rabbitsExp Eye Res19935632752798386101
   PubMed Web of Science ®Google Scholar
• KulkarniPSSrinivasanBDCyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctivaProg Clin Biol Res198931239522508129
   PubMedGoogle Scholar
• McGheeCNDeanSDanesh-MeyerHLocally administered ocular corticosteroids: benefits and risksDrug Saf2002251335511820911
   PubMed Web of Science ®Google Scholar
• AbadiaBCalvoPFerrerasABartolFVerdesGPabloLClinical applications of dexamethasone for aged eyesDrugs Aging201633963964627566619
   PubMed Web of Science ®Google Scholar
• MasferrerJLKulkarniPSCyclooxygenase-2 inhibitors: a new approach to the therapy of ocular inflammationSurv Ophthalmol199741Suppl 2S35S409154274
   PubMed Web of Science ®Google Scholar
• RazAWycheANeedlemanPTemporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phasesProc Natl Acad Sci U S A1989865165716612493647
   PubMed Web of Science ®Google Scholar
• BhagatRZhangJFarooqSLiXYComparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyesJ Ocul Pharmacol Ther2014301085485825411827
   PubMed Web of Science ®Google Scholar
• CholkarKPatelSPVadlapudiADMitraAKNovel strategies for anterior segment ocular drug deliveryJ Ocul Pharmacol Ther201329210612323215539
   PubMed Web of Science ®Google Scholar
• TasmanWJaegerEADuane’s OphthalmologyPhiladelphia, PALippincott Williams & Wilkins2009
   Google Scholar
• GaudanaRAnanthulaHKParenkyAMitraAKOcular drug deliveryAAPS J201012334836020437123
   PubMed Web of Science ®Google Scholar
• AhmedIPattonTFImportance of the noncorneal absorption route in topical ophthalmic drug deliveryInvest Ophthalmol Vis Sci19852645845873884542
   PubMed Web of Science ®Google Scholar
• UrttiAPipkinJRorkGSendoTFinneUReptaAControlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbitsInt J Pharm1990613241249
   Web of Science ®Google Scholar
• MannermaaEVellonenKSUrttiADrug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokineticsAdv Drug Deliv Rev200658111136116317081648
   PubMed Web of Science ®Google Scholar
• KarlaPKEarlaRBodduSHJohnstonTPPalDMitraAMolecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cellsCurr Eye Res20093411919172464
   PubMed Web of Science ®Google Scholar
• KarlaPKPalDMitraAKMolecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cellsExp Eye Res2007841536017083930
   PubMed Web of Science ®Google Scholar
• DeySPatelJAnandBSMolecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell linesInvest Ophthalmol Vis Sci20034472909291812824231
   PubMed Web of Science ®Google Scholar
• KimSHLutzRJWangNSRobinsonMRTransport barriers in transscleral drug delivery for retinal diseasesOphthalmic Res200739524425417851264
   PubMed Web of Science ®Google Scholar
• CivialeCBucariaFPiazzaSPeriOMianoFEneaVOcular permeability screening of dexamethasone esters through combined cellular and tissue systemsJ Ocul Pharmacol Ther2004201758415006161
   PubMed Web of Science ®Google Scholar
• KassemMAAbdel RahmanAAGhorabMMAhmedMBKhalilRMNanosuspension as an ophthalmic delivery system for certain gluco-corticoid drugsInt J Pharm20073401–212613317600645
   PubMed Web of Science ®Google Scholar
• PepićIHafnerALovrićJPirkićBFilipović-GrcićJA nonionic surfactant/chitosan micelle system in an innovative eye drop formulationJ Pharm Sci201099104317432520310026
   PubMed Web of Science ®Google Scholar
• HosseiniKMatsushimaDJohnsonJPharmacokinetic study of dexamethasone disodium phosphate using intravitreal, subconjunctival, and intravenous delivery routes in rabbitsJ Ocul Pharmacol Ther200824330130818476800
   PubMed Web of Science ®Google Scholar
• KimSJEquiRBresslerNMAnalysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomographyOphthalmology2007114588188917275910
   PubMed Web of Science ®Google Scholar
• CalvoPFerrerasAAl AdelFDangboonWBrentMHEffect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgeryRetina201838349049628196056
   PubMed Web of Science ®Google Scholar
• ParisCLPeymanGAGremillionCMBlinderKJIntravitreal dex-amethasone following vitreous surgeryInt Ophthalmol19911531731742050472
   PubMed Web of Science ®Google Scholar
• NabihMPeymanGATawakolMENaguibKToxicity of high-dose intravitreal dexamethasoneInt Ophthalmol19911542332351917317
   PubMed Web of Science ®Google Scholar
• KanskiJJClinical ophthalmologyA Systematic Approach2nd edBurlington, MAButterworth-Heinemann2007629
   Google Scholar
• VengatesanMRMittalVNanoparticle- and Nanofiber-Based Polymer Nanocomposites: An OverviewWiley Spherical and Fibrous Filler CompositesWeinheim, GermanyWiley-VCH20161138
   Google Scholar
• MamalisNEdelhauserHFDawsonDGChewJLeboyerRMWernerLToxic anterior segment syndromeJ Cataract Refract Surg200632232433316565012
   PubMed Web of Science ®Google Scholar
• GoelMPiccianiRGLeeRKBhattacharyaSKAqueous humor dynamics: a reviewOpen Ophthalmol J20104525921293732
   PubMedGoogle Scholar
• United States Food and Drug AdministrationDexycu Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208912s000lbl.pdfAccessed June 3, 2018
   Google Scholar
• ShaikhSVermaHYadavNJauhariMBullangowdaJApplications of steroid in clinical practice: a reviewISRN Anesthesiol201220127111
   Google Scholar
• LeeDJIntraocular implants for the treatment of autoimmune uveitisJ Funct Biomater20156365066626264035
   PubMedGoogle Scholar
• HaghjouNSoheilianMAbdekhodaieMJSustained release intraocular drug delivery devices for treatment of uveitisJ Ophthalmic Vis Res20116431731922454753
   PubMedGoogle Scholar
• LeeSSHughesPRossADRobinsonMRBiodegradable implants for sustained drug release in the eyePharm Res201027102043205320535532
   PubMed Web of Science ®Google Scholar
• LeeSYCheeSPBalakrishnanVFarzavandiSTanDTSuro-dex in paediatric cataract surgeryBr J Ophthalmol200387111424142614609850
   PubMed Web of Science ®Google Scholar
• WangJJiangAJoshiMChristoforidisJDrug delivery implants in the treatment of vitreous inflammationMediators Inflamm2013201318
   Web of Science ®Google Scholar
• DurairajCOcular pharmacokineticsHandb Exp Pharmacol2017242315527787714
   PubMedGoogle Scholar
• NavratilTGarciaATullyJPreclinical Evaluation of ENV515 (travoprost) Intracameral Implant-Clinical Candidate for Treatment of Glaucoma Targeting Six-Month Duration of ActionInvestigative Ophthalmology & Visual Science2014551335483548
   Web of Science ®Google Scholar
• El-MaghrabyAMarzoukiAMatheenTMSouchekJvan der KarrMReproducibility and validity of laser flare/cell meter measurements of intraocular inflammationJ Cataract Refract Surg199319152558426323
   PubMed Web of Science ®Google Scholar
• SawaMTsurimakiYTsuruTShimizuHNew quantitative method to determine protein concentration and cell number in aqueous in vivoJpn J Ophthalmol19883221321423054216
   PubMed Web of Science ®Google Scholar
• ChangDTHercegMCBilonickRACamejoLSchumanJSNoeckerRJIntracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucomaClin Ophthalmol20093134535519668589
   PubMedGoogle Scholar
• KesselLTendalBJørgensenKJPost-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic reviewOphthalmology2014121101915192424935281
   PubMed Web of Science ®Google Scholar
• HirneißCNeubauerASKampikASchönfeldCLComparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction. A prospective, randomized, double-masked studyGraefe’s Arch Clin Exp Ophthalmol2005243876877315756571
   PubMed Web of Science ®Google Scholar
• El-HaraziSMRuizRSFeldmanRMVillanuevaGChuangAZA randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cellsOphthalmic Surg Lasers19982975395449674003
   PubMedGoogle Scholar
• AsanoSMiyakeKOtaIReducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%J Cataract Refract Surg2008341576318165082
   PubMed Web of Science ®Google Scholar
• EndoNKatoSHaruyamaKShojiMKitanoSEfficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetesActa Ophthalmol201088889690019725815
   PubMed Web of Science ®Google Scholar
• MiyanagaMMiyaiTNejimaRMaruyamaYMiyataKKatoSEffect of bromfenac ophthalmic solution on ocular inflammation following cataract surgeryActa Ophthalmol200987330030519183412
   PubMed Web of Science ®Google Scholar
• WangQWYaoKXuWBromfenac sodium 0.1%, fluo-rometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemul-sificationOphthalmologica2013229418719423429038
   PubMed Web of Science ®Google Scholar
• PleyerUUrsellPGRamaPIntraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?Ophthalmol Ther201322557225135807
   PubMedGoogle Scholar
• RothDBRealiniTFeuerWJShort-term complications of intravit-real injection of triamcinolone acetonideRetina2008281667018185140
   PubMed Web of Science ®Google Scholar
• InataniMIwaoKKawajiTIntraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control studyAm J Ophthalmol2008145467668118243153
   PubMed Web of Science ®Google Scholar
• KaralezliABorazanMAkovaYAIntracameral triamcinolone ace-tonide to control postoperative inflammation following cataract surgery with phacoemulsificationActa Ophthalmol200886218318718162061
   PubMed Web of Science ®Google Scholar
• KwakHWD’AmicoDJEvaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injectionArch Ophthalmol199211022592661736876
   PubMed Web of Science ®Google Scholar
• DineenBBourneRRJadoonZCauses of blindness and visual impairment in Pakistan. The Pakistan national blindness and visual impairment surveyBr J Ophthalmol20079181005101017229806
   PubMed Web of Science ®Google Scholar
• FisherBLPotvinRTranszonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgeryClin Ophthalmol2016101297130327486301
   PubMedGoogle Scholar
• AnJAKasnerOSamekDALévesqueVEvaluation of eyedrop administration by inexperienced patients after cataract surgeryJ Cataract Refract Surg201440111857186125248295
   PubMed Web of Science ®Google Scholar
• BrownMMBrownGCSpaethGLImproper topical self-administration of ocular medication among patients with glaucomaCan J Ophthalmol1984191256608974
   PubMed Web of Science ®Google Scholar